Skip to content
Oliceridine
Olinvyk (oliceridine) is a small molecule pharmaceutical. Oliceridine was first approved as Olinvyk on 2020-10-30. It is used to treat acute pain in the USA.
Download report
Favorite
FDA Novel Drug Approvals 2020
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Olinvyk
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Oliceridine
Tradename
Company
Number
Date
Products
OLINVYKTrevenaN-210730 RX2020-10-30
3 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
olinvykNew Drug Application2021-03-16
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
acute pain—D059787R52
Agency Specific
FDA
EMA
Expiration
Code
OLICERIDINE, OLINVYK, TREVENA
2025-10-30NCE
Patent Expiration
Patent
Expires
Flag
FDA Information
Oliceridine, Olinvyk, Trevena
88354882032-03-23DS, DPU-2986
93092342032-03-23DS, DPU-2986
96428422032-03-23DPU-2986
110770982032-03-23DS, DPU-2986
ATC Codes
N: Nervous system drugs
— N02: Analgesics
— N02A: Opioid analgesics
— N02AX: Other opioids in atc
— N02AX07: Oliceridine
HCPCS
No data
Clinical
Clinical Trials
12 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Acute painD059787R521131—6
Respiratory insufficiencyD012131HP_0002093J96.9———1—1
Drug-related side effects and adverse reactionsD064420T88.7———1—1
Postoperative nausea and vomitingD020250EFO_0004888———1—1
BurnsD002056T30.0———1—1
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PainD010146EFO_0003843R52—2———2
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients—3————3
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOLICERIDINE
INNoliceridine
Description
Oliceridine, sold under the brand name Olinvyk, is an opioid medication that is used for the treatment of moderate to severe acute pain in adults. It is given by intravenous (IV) injection.
Classification
Small molecule
Drug classanalgesics (meperidine type)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1
Identifiers
PDB—
CAS-ID1401028-24-7
RxCUI—
ChEMBL IDCHEMBL2443262
ChEBI ID—
PubChem CID66553195
DrugBankDB14881
UNII IDMCN858TCP0 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 291 documents
View more details
Safety
Black-box Warning
Black-box warning for: Olinvyk
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
7,497 adverse events reported
View more details